Manoj Khadka: Omega-3s and Cardiovascular Outcomes in Hemodialysis
Manoj Khadka, Resident Doctor at Patan Hospital, shared a post on LinkedIn, about recent article by Charmaine E. Lok et al., published in NEJM, adding:
“Pleased to share my journal abstract presentation reviewing the PISCES trial, published in NEJM (Nov 2025), which evaluated the impact of omega-3 fatty acid (fish oil) supplementation on cardiovascular events in patients undergoing maintenance hemodialysis.
The presentation focused on the study methodology, key findings, clinical implications, and future directions regarding the role of fish oil in cardiovascular risk reduction among dialysis patients.”
Title: Fish Oil Supplementation Reduces Cardiovascular Events in Hemodialysis Patient
Authors: Charmaine E. Lok, M.D., Michael Farkouh, M.D., Brenda R. Hemmelgarn, M.D., Ph.D., Louise M. Moist, M.D., Kevan R. Polkinghorne, M.B., Ch.B., Ph.D., George Tomlinson, Ph.D., Paul Tam, M.D., Marcello Tonelli, M.D. and Jacob A. Udell, M.D., M.P.H.
Stay updated on all scientific advances with Hemostasis Today.
-
Aug 11, 2026, 11:38Maria Hadjidemetriou: The Patient Perspective in Thalassemia Care
-
Aug 11, 2026, 11:04Wolfgang Miesbach: The Critical Need for Tailored Dosing in VWD
-
Aug 11, 2026, 08:20Hasan Abbas Zaheer: Strengthening Universal Access to Safe Blood in Pakistan
-
Aug 11, 2026, 08:07Nicola Pozzi: Advancing Hemostasis Through Scientific Collaboration at Hemostasis GRC
-
Aug 11, 2026, 07:50When Access to Care Changes Everything – WFH
-
Aug 11, 2026, 07:41Kevin Land: How Cellular Therapy Is Changing Transfusion Medicine
-
Aug 11, 2026, 07:35Kuldeep Singh Bhadauria: Building the Future of Hemophilia Care in India
-
Aug 11, 2026, 07:28Archil Jaliashvili: When Every Minute Matters Time Becomes a Therapy
-
Aug 11, 2026, 07:05Mavis Agnes Kisakye: Building Sustainable Transition Pathways in Hemophilia Care